4//SEC Filing
Harris Erik 4
Accession 0001209191-23-048491
CIK 0001515673other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:51 PM ET
Size
5.2 KB
Accession
0001209191-23-048491
Insider Transaction Report
Form 4
Harris Erik
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-09-05$37.96/sh−6,000$227,760→ 51,281 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.95 to $38.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001780113
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:51 PM ET
- Size
- 5.2 KB